PRESS RELEASE published on 02/16/2026 at 07:30, 4 months 26 days ago Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470 Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470, confirmant le dépôt de la NDA pour l'été 2026. Collaboration avec Kowa et avancée vers l'autorisation de mise sur le marché FDA Nicox NCX 470 Réunion Pré-NDA Autorisation De Marché
BRIEF published on 02/12/2026 at 07:35, 5 months 2 days ago Nicox maintains its PEA-PME status for 2026 PEA-PME Euronext Growth Paris Investment Ophthalmology Nicox
BRIEF published on 02/12/2026 at 07:35, 5 months 2 days ago Nicox maintient son statut PEA-PME pour 2026 PEA-PME Euronext Growth Paris Investissement Ophtalmologie Nicox
PRESS RELEASE published on 02/12/2026 at 07:30, 5 months 2 days ago Nicox confirme son éligibilité au PEA-PME Nicox confirme son éligibilité au PEA-PME pour l'année à venir, permettant aux investisseurs de continuer à intégrer ses actions dans les comptes PEA PME PEA-PME Investissement Fiscalité Ophtalmologie Nicox
BRIEF published on 02/10/2026 at 07:35, 5 months 4 days ago Nicox présentera des données clés lors de la réunion annuelle de l'AGS en 2026. Essais Cliniques Nicox NCX 470 Glaucome AGS 2026
BRIEF published on 02/10/2026 at 07:35, 5 months 4 days ago Nicox to Present Key Data at AGS Annual Meeting 2026 Clinical Trials Glaucoma Nicox NCX 470 AGS 2026
PRESS RELEASE published on 02/10/2026 at 07:30, 5 months 4 days ago Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026 Nicox to present NCX 470 Phase 3 data at AGS Annual Meeting 2026 with podium presentations showcasing clinical study results and efficacy of the ophthalmic solution Clinical Study Ophthalmology Nicox NCX 470 AGS Annual Meeting 2026
PRESS RELEASE published on 02/10/2026 at 07:30, 5 months 4 days ago Nicox : Présentation des données des études de Phase 3 de NCX 470 au congrès annuel 2026 de l’American Glaucoma Society (AGS) Nicox présente les données des études de Phase 3 de NCX 470 au congrès annuel 2026 de l'AGS, démontrant l'efficacité de leur nouveau produit pour le glaucome Ophtalmologie Nicox NCX 470 Études De Phase 3 Congrès AGS
BRIEF published on 01/20/2026 at 07:35, 5 months 25 days ago Nicox Announces 2026 Conference Participation and Data Presentations Scientific Data Ophthalmology NCX 470 Conference Participation 2026 Events
BRIEF published on 01/20/2026 at 07:35, 5 months 25 days ago Nicox annonce sa participation à la conférence de 2026 et la présentation de ses données. Ophtalmologie NCX 470 Participation À La Conférence Événements De 2026 Données Scientifiques
Published on 07/14/2026 at 22:30, 29 minutes ago Hillcrest Energy Technologies Announces Board and Leadership Changes Following 2026 Annual General Meeting
Published on 07/14/2026 at 22:30, 29 minutes ago Loop Industries Reports First Quarter Fiscal 2027 Results and Provides Update on Progress Towards Commercialization
Published on 07/14/2026 at 16:40, 6 hours 19 minutes ago AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation
Published on 07/14/2026 at 15:45, 7 hours 14 minutes ago Silver Storm Commences Hot Commissioning of the La Parrilla Sulphide Circuit, Amends the Samsung Prepayment Agreement, and Secures US$5 Million Loan from First Majestic
Published on 07/14/2026 at 15:15, 7 hours 44 minutes ago Gratomic Inc. Provides Corporate Update for Shareholders
Published on 07/14/2026 at 19:14, 3 hours 45 minutes ago EQS-Adhoc: Nagarro SE: BaFin Enforcement Review of the 2022 Consolidated Financial Statements
Published on 07/14/2026 at 18:17, 4 hours 42 minutes ago EQS-Adhoc: Delivery Hero confirms advanced negotiations with Uber Technologies in respect to potential takeover offer
Published on 07/14/2026 at 17:51, 5 hours 8 minutes ago Aumann announces share buyback with an allotment ratio of approximately 6%
Published on 07/14/2026 at 17:30, 5 hours 29 minutes ago NABR: The U.S. Fish and Wildlife Service for the Second Time Rejects Activists' Petition to List Long-Tailed Macaque Monkeys Under the Endangered Species Act
Published on 07/14/2026 at 17:28, 5 hours 31 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 07/13/2026 at 18:00, 1 day 4 hours ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 1 day 4 hours ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 1 day 4 hours ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
